GB1406061A - Medicament formulations containing 6-alkoxypyridzinium compounds - Google Patents
Medicament formulations containing 6-alkoxypyridzinium compoundsInfo
- Publication number
- GB1406061A GB1406061A GB3649972A GB3649972A GB1406061A GB 1406061 A GB1406061 A GB 1406061A GB 3649972 A GB3649972 A GB 3649972A GB 3649972 A GB3649972 A GB 3649972A GB 1406061 A GB1406061 A GB 1406061A
- Authority
- GB
- United Kingdom
- Prior art keywords
- alkoxypyridzinium
- compounds
- formulations containing
- aug
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000009472 formulation Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 abstract 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 239000002269 analeptic agent Substances 0.000 abstract 1
- 150000001450 anions Chemical class 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 229960001948 caffeine Drugs 0.000 abstract 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 230000000747 cardiac effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 239000005526 vasoconstrictor agent Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19712139687 DE2139687C2 (de) | 1971-08-07 | 1971-08-07 | Verwendung von Verbindungen bei der Steigerung des Blutdruckes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1406061A true GB1406061A (en) | 1975-09-10 |
Family
ID=5816135
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB3649972A Expired GB1406061A (en) | 1971-08-07 | 1972-08-04 | Medicament formulations containing 6-alkoxypyridzinium compounds |
| GB1315075A Expired GB1406062A (en) | 1971-08-07 | 1972-08-04 | Medicament formulations containing 6-methoxypyridazinium compounds |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1315075A Expired GB1406062A (en) | 1971-08-07 | 1972-08-04 | Medicament formulations containing 6-methoxypyridazinium compounds |
Country Status (5)
| Country | Link |
|---|---|
| BE (1) | BE787275A (enExample) |
| DE (1) | DE2139687C2 (enExample) |
| FR (1) | FR2150745B1 (enExample) |
| GB (2) | GB1406061A (enExample) |
| ZA (1) | ZA725359B (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4820821A (en) * | 1981-11-06 | 1989-04-11 | Basf Aktiengesellschaft | Novel pyridazinone-imines and their physiologically tolerated addition salts with acids, their preparation and therapeutic agents containing these compounds |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1912941C3 (de) * | 1969-03-14 | 1980-06-26 | Basf Ag, 6700 Ludwigshafen | 1 -Phenyl^-amino-e-methoxypyridaziniumsalze |
-
0
- BE BE787275D patent/BE787275A/xx not_active IP Right Cessation
-
1971
- 1971-08-07 DE DE19712139687 patent/DE2139687C2/de not_active Expired
-
1972
- 1972-08-04 ZA ZA725359A patent/ZA725359B/xx unknown
- 1972-08-04 GB GB3649972A patent/GB1406061A/en not_active Expired
- 1972-08-04 GB GB1315075A patent/GB1406062A/en not_active Expired
- 1972-08-07 FR FR7228483A patent/FR2150745B1/fr not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4820821A (en) * | 1981-11-06 | 1989-04-11 | Basf Aktiengesellschaft | Novel pyridazinone-imines and their physiologically tolerated addition salts with acids, their preparation and therapeutic agents containing these compounds |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2150745B1 (enExample) | 1976-08-20 |
| ZA725359B (en) | 1973-05-30 |
| FR2150745A1 (enExample) | 1973-04-13 |
| DE2139687A1 (de) | 1973-02-15 |
| DE2139687C2 (de) | 1985-01-24 |
| BE787275A (fr) | 1973-02-07 |
| GB1406062A (en) | 1975-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ330369A (en) | aqueous medicaments containing 9-hydroxy-risperidone fatty acid ester | |
| GB1418208A (en) | Pharmaceutical compositions | |
| GB1081577A (en) | Scopolamine esters and acid addition salts thereof useful as anti-perspirant agents | |
| GB1399834A (en) | Pharmaceutical compositions | |
| GB1487334A (en) | Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof | |
| GB1174051A (en) | Aminophenol Derivatives and Analgesic and Antipyretic Compositions | |
| OA07029A (fr) | Le chlorure de gallium, nouveau médicament anti-cancéreux. | |
| KR930023338A (ko) | 데포우 제제 | |
| GB1464467A (en) | Pharmaceutical composition for the treatment of coronary | |
| GB1322112A (en) | 3,4,5-trimethoxybenzoic acid derivatives and their uses | |
| GB1160597A (en) | Novel Isoxazolo[5,4-6]Pyridines and the Preparation Thereof | |
| ES342394A1 (es) | Procedimiento para la produccion de nuevas 2-bencilamino-i-mida-zolinas-(2). | |
| IE39679L (en) | Methods and compositions for killing parasites of warm¹blooded animals | |
| GB1352392A (en) | Phenylisopropylamine derivatives | |
| ES363591A1 (es) | Un procedimiento para la produccion de derivados de fenile-tilamina. | |
| GB1406062A (en) | Medicament formulations containing 6-methoxypyridazinium compounds | |
| GB1359044A (en) | Quinoline derivatives | |
| GB1464082A (en) | Pharmaceutical 'ompositions containing benzylamines | |
| GB1375806A (enExample) | ||
| GB1176049A (en) | N-Substituted Noratropinium Salts | |
| ES393894A1 (es) | Procedimiento para la obtencion de 1-metil-3- ((p-metil- alfa-fenil-bencil) oximetil) piperidina y sus sales de adi- cion y de amonio cuaternario. | |
| GB1465771A (en) | Pharmaceutical composition and use thereofd | |
| GB1420976A (en) | Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children | |
| GB1279380A (en) | Improvements in or relating to hydantoins and compositions thereof | |
| ES355205A1 (es) | Procedimiento para la preparacion de alcohol alfa - (1 - a-minoetil)-m - metoxibencilico. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PCNP | Patent ceased through non-payment of renewal fee |